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บทคดัยอ่  
วตัถปุระสงค:์ เพือ่พฒันาระบบการดแูลดา้นยาโดยเภสชักรในคลนิิกโรคไม่ตดิต่อ
เรื้อรงัทีม่คีวามเหมาะสมกบับรบิทของโรงพยาบาลด าเนินสะดวก วิธีการศึกษา: 
การวจิยัเชงิปฏบิตักิารแบบมสี่วนร่วมและกระบวนการพฒันาแบบต่อเนื่อง เก็บ
ขอ้มูลระหว่างพฤศจกิายน 2559 ถงึกนัยายน 2560 จากบุคลากรทางการแพทย์ 
14 คน ร่วมกันวิเคราะห์ปัญหา ออกแบบและทดสอบระบบ แล้วน าระบบที่
พฒันาขึ้นไปดูแลผู้ป่วยโรคไม่ตดิต่อเรื้อรงั ตามแนวคดิองค์ประกอบ CCM และ
การพฒันาแบบวงลอ้ PDCA ผลการศึกษา: ระบบการดแูลดา้นยาโดยเภสชักรที่
พฒันาขึ้นประกอบด้วยการท างานของเภสชักร 3 ขัน้ตอน คอื 1. การคดักรอง
ปัญหาดา้นยาโดยใช้ระบบเทคโนโลยสีารสนเทศและจากการซกัประวตัขิองเภสชั
กร 2. การจดัการดา้นยา และ 3. การส่งต่อขอ้มูลแก่บุคลากรทางการแพทย์และ
ผู้ป่วย ในการพฒันาระบบอาศยัทุกองค์ประกอบของรูปแบบการดูแลโรคเรื้อรงั 
โดยมเีป้าหมายและทศิทางเป็นองค์ประกอบเริม่ตน้ในการพฒันา ซึง่ระหว่างการ
ด าเนินงานต้องใช้ทัง้ระบบสารสนเทศ การปรบัระบบและกระบวนการบรกิาร 
ระบบการสนับสนุนการจดัการตนเอง และระบบการสนับสนุนการตดัสนิใจ พบว่า
ระบบสารสนเทศมคีวามส าคญัตอ่การพฒันาระบบการดูแลดา้นยามากทีสุ่ด ระบบ
ทีพ่ฒันาขึ้นสามารถคดักรองปัญหาทีค่าดว่าเกี่ยวขอ้งกบัยาก่อนวนันัดไดร้้อยละ 
17.8 และในวนันดัคดักรองไดร้อ้ยละ 42.7 ปัญหาสว่นใหญ่ทีพ่บ คอื ผูป่้วยบรหิาร
ยาผดิ (รอ้ยละ 67.6) พบวา่แพทยใ์หก้ารรกัษาทีส่อดคลอ้งกบัขอ้มลูทีส่ง่ตอ่ใหร้อ้ย
ละ 63.6 สรปุ: บทบาทเภสชักรในทมีสหสาขาวชิาชพีโดยการท างานเชงิรุกอาศยั
ระบบเทคโนโลยีสารสนเทศและการซักประวตัิโดยเภสัชกรร่วมกันสามารถ
สนบัสนุนใหก้ารจดัการดา้นยาในผูป่้วยโรคตดิตอ่เรือ้รงัไดเ้หมาะสมยิง่ขึน้  
ค าส าคญั : ระบบการดูแลด้านยา, วจิยัแบบมสี่วนร่วม, เภสชักร, ทมีสหสาขา
วชิาชพี, โรคไมต่ดิตอ่เรือ้รงั, วงจรพดีซีเีอ, โมเดลการดแูลโรคเรือ้รงั   
 
 
 
 
 
Abstract 
Objective: To develop a drug therapy management system with pharmacist 
participating in multidisciplinary team suitable for the non- communicable 
disease (NCD) clinic of Damnoensaduak Hospital. Method: This participatory 
action research (PAR)  was performed from November 2016 to September 
2017. Fourteen healthcare providers were selected to be in the PAR team to 
coordinate analysis, design based on the components of Chronic Care Model 
(CCM) concept, and implementation of the developed system using the Plan-
Do- Check- Act ( PDCA)  cycle.  Results:  The developed drug therapy 
management system consisted of three roles of pharmacists, namely ( 1) 
screening drug related problems (DRP)  using information technology and 
history taking, (2) drug therapy management, and (3) communication of the 
patient’s information to the team and patient. All components of CCM could 
be implemented.  Resource and policy were the initial components for 
development. During the ongoing process, other components namely clinical 
information systems, delivery system design, self-care support and decision-
making support were applied with the information system component as the 
most important one. The developed system could screen 17.8% and 42.7% 
DRPs before and on the appointment day, respectively.  Most DRPs were 
errors in patient’s self-administration (67.6%). The physician responded to 
the DRP in agreement with the information communicated by pharmacist by 
63.6%. Conclusion: The proactive role of pharmacist using the information 
technology and history taking in the multidisciplinary team could offer an 
effective drug therapy in NCD patients.  
Keywords:  drug therapy management system, participatory action 
research, pharmacist, multidisciplinary team, non- communicable disease, 
PDCA cycle, chronic care model   
  
 
Introduction 
Non- communicable disease ( NCD)  has become a 
significant burden on health worldwide since they are the 
major causes of disability and premature mortality. In addition, 
NCD related illnesses affect not only the patients, but also 
family member, either physically, mentally or emotionally, or 
combined. Overall, NCD could impair the economic and social 
development. There has been a trend of increased number of 
NCD patients annually as well as NCD related deaths and 
hospitalizations. 1,2 Since diabetes mellitus and hypertension 
are the two most prominent NCDs, inadequate treatment 
and/ or poor control on the two NCDs could lead to 
complications ranging from heart failure, cerebrovascular 
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diseases, ischemic heart disease, kidney failure, retinopathy 
and stroke.  With these grave consequences of these two 
NCDs, early screening on these two NCDs could enable an 
early access to proper treatment, control or modify risk factors, 
delay the disease progression, and eventually alleviate the 
healthcare burden, expenditure and loss of health and quality 
of life.  
Recently there has been NCD management system with 
multidisciplinary team.  With its proactive approach, the two 
core components are as follows.  First, the patient and family 
hold the central role of proactive action for self- care 
management.  The second part is the management system 
with the multidisciplinary team for the continuity of care.3,4 To 
develop such solid healthcare system, one of the model that 
several countries have adopted is the Chronic Care Model 
(CCM) of Wagner and colleagues.5,6 CCM consists of 6 related 
components including 1) health organization policy, 2) clinical 
informatic system, 3)  decision making system, 4)  healthcare 
service system, 5)  self-care support, and 6)  connection with 
community.  CCM expects healthcare providers to improve 
their service to fit the mutual expectation, supports 
collaboration, and encourage a systematic network of care for 
NCD. In addition, CCM expects that the multidisciplinary team 
create a proactive interaction between patients and healthcare 
providers.  In accordance with the present concept of quality 
assurance, individual components of CCM are used to help 
develop the patient care process through the continuous 
improvement based on the PDCA quality improvement 
concept of Deming. 7 According Deming, the improvement 
cycle consists of planning (Plan-P), the execution of the plan 
(Do-D) , the examination after the execution (Check-C) , and 
the improvement (Act-A). After a complete systematic cycle of 
PDCA, a more systematic working process and/ or a quality 
working process could be achieved.  In NCD care context, 
PDCA could bring a quality healthcare management system 
for NCD patients, providers, family, caregivers, community, 
and other related parties.  
The use of CCM components with the continuous 
improvement process of PDCA could be done with 
participatory action research (PAR)  which also support the 
proactive approach for integrated NCD healthcare system. 
PAR encourages participations of all involving parties. PAR is 
usually used in developing new system or improving existing 
system.  The process of PAR allows for information from all 
active parties.  This kind of information is more diverse and 
applicable for a timely improvement or correction.  The PAR 
process could thus lead to a quality healthcare service 
process, which could further lead to better clinical outcomes 
for patients and satisfaction for healthcare providers.8-10  
In Thailand, the Ministry of Public Health (MOP)  requires 
hospitals under its supervision to establish NCD clinic in 
2013. 3  However, despite a clear policy and support for 
execution, all components of CCM have not been clearly 
implemented in the process of care.  In addition, the systems 
of development and continuous evaluation have not been fully 
integrated.3  
Guided by the MOP, Damnoensaduak Hospital has 
established an NCD clinic for diabetes and hypertension to 
offer care by multidisciplinary team.  However, the care has 
been provided mainly by physicians and nurses, not all related 
professionals.  Mainly the passive aspect of care has been 
provided by pharmacists, specifically solving drug related 
problems identified and referred by nurses.  With the concern 
on a more involvement of pharmacists in the NCD clinic, this 
study aimed to develop a proactive drug therapy management 
system in the multidisciplinary team as guided by the CCM 
components in the PDCA development cycle. The developed 
system could be beneficial for the care of NCD patients, 
especially drug therapy management.    
     
Methods 
 
In this participatory action research ( PAR) , the 
investigators involved in all steps of the research.  All 
professionals in the multidisciplinary team were encouraged 
to participate in identifying, analyzing and solving drug therapy 
problems, as well as developing the drug therapy 
management system with the participation of pharmacists in 
the NCD clinic of Damnoensaduak Hospital, Ratchaburi 
province. 
This study was approved by the Ethic Committee for 
Human Research of Faculty of Pharmacy, Silpakorn University 
(Approval number: 4/2559; approval date: October 3, 2016). 
The study was conducted from November 30, 2016 to 
September 15, 2017.  
In this study, drug therapy management system was 
defined as a proactive integrated planning of drug therapy by 
multidisciplinary system through out the entire duration of 
disease prognosis, as well as the prevention of drug- related 
adverse events.  The system was expected to provide useful 
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information both for providers and patients which could be the 
patient confidence with proper drug therapy.   
 
Study participants  
Two groups of participants were recruited namely ( 1) 
multidisciplinary team participating the development of drug 
therapy management system and (2)  patients receiving care 
provided by the multidisciplinary team.  Participants were 
selected by purposive sampling method. The inclusion criteria 
were providers in the NCD service of Damnoensaduak 
Hospital.  This group of providers participated in problem 
analysis, system development, and implementation of the 
developed system.  
The process of the study was continuous with the PDCA 
cycle. We divided the study into three phases as follows. First, 
the planning for drug management system based on the 
development objectives (Plan-P) .  Second, the execution of 
the plan (Do-D)  and the evaluation of the execution (Check-
C) .  Third, the modification after the evaluation for further 
improvement (Act-A). Details are shown in Figure 1. 
In terms of healthcare provider participants, they were 
divided into three phases according to the study phases.  In 
the first phase, 13 providers in the care of NCD patients were 
included.  In the second phase, 9 providers involving in care 
of NCD patients were included.  These were physicians, 
nurses, health educators, and pharmacist ( the first 
investigator) .  Of these 9 participants, 4 of them were 
participants from the first phase.  In the third phase, 14 
providers in the NCD care were physicians, nurses, health 
educators and regular staff pharmacists in the NCD clinic. Of 
these 14 providers, 6 of them were from the second phase 
(Figure 1).  
For patients receiving care provided by the 
multidisciplinary team, all patients followed up in the NCD 
clinic during study period of the developed system were 
recruited.  Providers were participants in the development of 
the drug therapy management system.  Details are shown in 
Figure 1.  Components of the drug therapy management 
system based on the Chronic Care Model (CCM) concept are 
depicted in Figure 2.   
 
Data collection  
Two kinds of data were collected. First, problems, possible 
solutions, opinions ( recommendations, critiques, etc. ) , and 
outputs during the system development were collected at all 
steps of study conduct.  Second, outputs during the system 
implementation were collected at phase 2 and 3 of study 
conduct.  
Data collection tools differed by phase of study.  In phase 
1 and 2, electronic database called HOSxP, hardcopy of 
patient’ s information receiving care at the out- patient 
department, video recorders to record all study process, for 
interviewing multidisciplinary team, screening form for drug 
related problems by pharmacists, and the form to collect 
problems and solutions during the development and 
implementation of the drug therapy management system.  In 
phase 3 where pharmacists regularly responsible in NCD clinic 
took care of the patients, we used the screening form for drug 
related problems by pharmacists and the form to collect 
problems and solutions during the development and 
implementation of the drug therapy management system.  In 
phase 3, the first investigator only observed the process and 
participated only when problems arose. 
All data were subject to analysis by the investigators with 
confidential.  The results were presented as a summary not 
individual patient data.  No identification information of the 
patients were presented so no individual patients could be 
identified.  
 
Data analysis  
In the qualitative analysis part, inductive summary to 
reach the important issues was based on the information from 
interviews with multidisciplinary team, team meeting, the 
implementation of the drug therapy management system with 
patients and providers.  The results of system development 
and implementation were presented along with the 
recommendations for improvement in the format guided by 
components of CCM concept. 
For quantitative analysis, frequency with percentage was 
used to present the numbers of 1)  patients undergoing 
screening for drug related problems, 2) drug related problems 
identified, the intervention by physicians that were in 
concordance with pharmacist’ s suggestions.  These results 
reflected the implementation of the drug therapy management 
system developed in our study. 
 
 
ไทยเภสชัศาสตรแ์ละวทิยาการสขุภาพ ปี 14 ฉบับ 3, กค. – กย. 2562  103 Thai Pharm Health Sci J Vol. 14 No. 3, Jul. – Sep. 2019 
 
  Figure 1  Procedure and participants in 3 phases of study.    
 
 
 Figure 2  Components of the drug therapy management system based on the Chronic Care Model (CCM) concept.  
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Results  
 
  The study results were divided into two parts.  The first 
part demonstrated the details of related situation and 
development of the drug therapy management system with 
pharmacists participating with multidisciplinary team.  In the 
second part, quantitative results after implementing the 
system were presented.  
 
Part I:  Related situation and development of the drug 
therapy management system with pharmacists 
participating with multidisciplinary team  
The present situation of the existing NCD clinic at 
Damnoensaduak Hospital  
At present, NCD clinic of Damnoensaduak Hospital were 
providing service 5 days a week.  Specifically, diabetes clinic 
was open on Monday, Tuesday and Friday; while 
hypertension clinic was on Wednesday and Thursday.  On a 
daily basis, about 50 –  100 patients were taken care of by 
physicians, nurses, pharmacists, social medicine officers, and 
laboratory workers.  Specifically, three physicians examined 
the patients, prescribed medications and order laboratory 
investigations for the next appointment.  
Among few nurses (i.e. 2 – 3) on duty at the NCD clinic, 
one of them was responsible for the direct NCD patient care. 
This on-duty nurse prepared medical chart a day before the 
appointment day. At the appointment before the patient could 
see the physician, the nurse screened for signs and symptoms 
of other co-morbidities, performed history taking, performed 
physical examinations especially basic vital signs, and 
recorded information from the screening into computer 
system.  After the appointment, the nurse recorded all 
information and laboratory orders for the next appointment into 
computer system.  
The other nurse assistant( s)  in the NCD clinic were 
responsible for preparing the hardcopy medical records.  Like 
the head nurse previously mentioned, these nurse assistants 
also screened for signs and symptoms of other co-morbidities, 
performed history taking, performed physical examinations 
especially basic vital signs, and recorded information from the 
screening into computer system. After the appointment, these 
nurse assistants also recorded all information and laboratory 
orders for the next appointment into computer system.  
For pharmacists, there were 2 to 4 of them at the NCD 
clinic.  These pharmacists were responsible for checking for 
proper prescriptions, dispensing the prescriptions, and 
providing advice and/ or solving drug related problems for all 
patients transferred from multidisciplinary team.  
For two workers in the social medicine team, one was a 
nurse acting as a case manager of NCD patients with 
problems.  This nurse was responsible for history taking, 
identifying and solving problems in patients with abnormal 
laboratory values, and improper drug administration.  Another 
person was a health educator responsible for solving 
problems and providing advice about lifestyle modification. 
NCD patients seeing social medicine team were usually 
transferred from the screening by physicians and/or nurses at 
the NCD clinic. For laboratory workers, they were responsible 
for collecting specimens for investigation as ordered by 
physicians, and reporting the findings to physicians via the 
electronic system (HOSxP).  
In terms of procedures of NCD service, the operations 
were divided into (1) days before the appointment and (2) on 
the appointment day.  Before appointment, the monthly-
assigned NCD nurse reviewed medical OPD charts of the 
appointed patients, and had the planned laboratory works for 
the next appointment ready on the OPD chart.  On the 
appointment day, the appointed patient presented their 
appointment document at the history taking point to be 
preliminarily screened by the NCD nurse. Once available, the 
patient met the physician for physical examination and 
consultation.  Once the session was over, the patient met the 
nurse for the next appointment document, laboratory order for 
next appointment, and prescriptions.  For some patients with 
problems, they might be transferred to social medicine team 
as indicated.  The criteria for transferring to social medicine 
team included (1)  blood pressure of > 1 4 0 / 9 0  mmHg, (2) 
fasting blood sugar (FBS) > 180 mg/dL, and/or HbA1C > 7%, 
(3)  total cholesterol > 200 mg/ dL, and or triglyceride > 150 
mg/ dL) , ( 4)  smoking history, or ( 5)  improper drug 
administration.  
 
Issues leading to the development of the drug therapy 
management system  
Based on the situation of the existing NCD clinic service 
mentioned above, four main issues were found problematic 
and deserved considerations for the development of the new 
drug therapy management system.  
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First: roles and responsibilities of the NCD clinic. It was 
found that the major healthcare providers were teams of 
physicians, nurses, and social medicine.  Roles and 
responsibilities of other professionals were unclear, including 
nutritionists and physical therapists were unclear.  For 
pharmacists, they had no proactive roles in identifying drug 
related problems, only provided pharmacy service to NCD 
patients like all other OPD ones.  These included examining 
prescriptions, dispensing medications and providing advice on 
proper drug use.  
Second:  the communication network and transferal of 
patient information. It was found that a small card was used 
to transfer or share information of the NCD patients (diabetes 
and hypertension). Since the care was relatively small, certain 
useful information was left out unrecorded especially 
medications which were briefly recorded as RM shortened for 
re-medication (i.e, refill for previous prescriptions). As a result, 
the thread of treatment information was disrupted which could 
further lead to treatment or medical errors. 
Third:  the workforce of responsible providers.  There 
was a lack of workforce to serve a relatively large number of 
NCD patients within a short period of time; hence, not all 
patients got screened.  
Fourth:  the importance of drug related information for 
patient care in the NCD clinic. Multidisciplinary team reported 
that drug related information was crucial for taking care of 
NCD patients. Information on the patient’s drug use behavior 
and evaluation on the appropriateness of prescriptions before 
seeing the physicians, if available, could be highly useful for 
multidisciplinary team with such as limited service time.  
Based on the issues mentioned above, we proposed three 
points for the development of the drug therapy 
management system as follows.  First, there was a need to 
enhance the role of pharmacists in the multidisciplinary team 
for NCD clinic.  Pharmacists should be responsible for 
identifying drug related problems before the patient met the 
physician, solving drug related problems, and transferring the 
information of drug related problems to the multidisciplinary 
team for a proper treatment plan.  
For the Second point for the system development, the 
drug therapy management system with more proactive role of 
pharmacists should be developed.  The system should be 
managed into three steps.  Step 1 involved screening drug 
related problems. The screening should be done at least one 
day before the appointment by pharmacists using the 
Pharmaceutical Care Network Europe ( PCNE)  to identify 
laboratory findings and previous medications from the hospital 
electronic medical record system (HOSxP) .  Step 2 should 
focus on drug therapy management system both with and 
without history taking.  For the drug therapy management 
system with no history taking, most drug related problems 
were about the physician prescription orders which the 
pharmacist could propose options of solution and inform the 
physician accordingly before the appointment.  For problems 
that needed history taking, they were about the patient’s actual 
use of medications thus history taking at the appointment 
should be conducted.  In step 3, information of identified drug 
related problems should be transferred to multidisciplinary 
team through the developed forms. Advice on medication use 
should be provided to the patients by pharmacists.  
Finally, the third point for development involved the 
development of the clear and continuous transferal of 
information.  The development of patient information forms 
either hardcopy or electronic, to shared among members of 
the multidisciplinary team and the information technology 
team.  The form should be ready for collecting the latest 
medication prescribed shared and printed from the HOSxP 
program, and drug related problems identified by the 
pharmacist.  
 
The development of the drug therapy management system 
based on the Chronic Care Model (CCM)  
Based on all three phases of the development, 
components of the drug therapy management system based 
on the Chronic Care Model (CCM)  were as follows.  For the 
first component, direction and policy, it was used to drive 
and oversee the development to better serve the NCD patients 
in accordance with those laid out by the Ministry of Public 
Health.  
In terms of the second component, informatic system, 
it was the crucial part of this development project.  Informatic 
system was used to guide the development of the form for 
transferring patient and medication information linked with the 
HOSxP software program.  The informatics system was also 
used in identifying drug related problems and sharing the 
problems among members of multidisciplinary team. 
Regarding the third component, system modification 
and service process, we developed a proactive drug therapy 
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management system as a part of NCD care. It was found that 
after implementation, the developed system helped identifying 
drug related problems, managing practical medication 
administration, and sharing drug information to both providers 
and patients.  
For the fourth component, self-care support system, 
this component was incorporated in the step of drug therapy 
management system with the patient participating in treatment 
plan.  It was found that pharmacist and patient together could 
identify drug related problems and adjust drug treatment plan 
to suit the patient’s lifestyle.  
For the fifth component, decision making support 
system, the transferal of patient information through the 
patient information form was developed to aid the physician 
and multidisciplinary team to timely design treatment plan. 
Finally, the sixth component, the community networking, had 
not been incorporated in this study.  Details of implemented 
components based on CCM are shown in Figure 2.  
 
The developed drug therapy management system   
The developed system was proactive in identifying and 
solving drug related problems before the patient could see the 
physician.  The system also helped taking a continuous care 
of drug use after appointment and the incorporation of the 
multidisciplinary team.  The process was divided into two 
phases, namely the process before and on the appointment 
day.  In both phases, pharmacists were involved in three 
steps.  
In step 1, identifying drug related problems was the first 
step for drug therapy management system.  With the 
availability of the hospital informatic system, two screening 
methods for identifying drug related problems were 
implemented.  The first preliminary screening was possible 
with the use of HOSxP program to retrieve information of 
patients unable to control their blood sugar and blood pressure 
(FBS > 180 mg/ dL and blood pressure > 160/ 100 mmHg, 
respectively) .  The second thorough screening by the 
pharmacist based on medication history and laboratory results 
from previous appointment from HOSxP for all patients 
registered in the NCD clinic.  
In step 2, drug therapy management was performed after 
identifying drug related problems in step 1.  Drug related 
problems that did not need history taking were mainly the 
problems related to physician’ s prescription pattern.  On the 
other hand, problems that needed history taking were related 
to the actual patient’ s compliance to drug regimen and drug 
administration. 
Finally, step 3 involved s transferal of information.  The 
transferal of patient information to members of 
multidisciplinary team was done via the transferal form 
developed in thus study.  Transferal of information to the 
patient was done mainly verbally regarding the purpose and 
administration of each drug as well as any modification in drug 
regimen. Details are also shown in figure 2.  
  
Part II:  quantitative results after implementing the 
developed drug therapy management system   
In the last phase of development, the drug therapy 
management system with pharmacists participating with 
multidisciplinary team was implemented.  With 5 pharmacists 
participating in a 5-week period, a total of 1,846 patients were 
included in the NCD clinic, where 1 , 035  (56.1%) and 811 
(43.9%) of them had diabetes and hypertension, respectively 
(Table 1).  
Of these 1,846 patients, 312 drug related events were 
screened with HosXP program.  However, once screened by 
the pharmacist, a total of 329 drug related events were found 
(17. 8%) .  Drug therapy management with no history taking 
was done in 13 patients (0.7%) with 13 drug related problems 
found; while 316 patients with history taking for suspected 
problems were helped with drug therapy management (17.1%) 
(Table 1).  
 
 Table 1  Number of patients screened for drug therapy 
management at the NCD clinic.   
Number of patients registered 
at NCD clinic by disease (%)  
Number of patients before appointment (%) 
Screened by 
HOSxP  
 
Screened by pharmacist 
Diabetes 
Hyper-
tension 
Total 
Number of 
patients  
with no 
history taking  
Number of 
patients  
with history 
taking  
Total number 
of patients 
screened 
1,035 
(56.1) 
811 
(43.9) 
1,846 
(100.0) 
312 
(16.9) 
13 
(0.7) 
316 
(17.1) 
329 
(17.8) 
 
Among 13 patients helped with drug therapy management 
with no history taking before appointment, 13 events of drug 
related problems were found with untreated indication as the 
most found problem (10 events or 76.9%) (Table 2).  
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 Table 2  Number of drug related problems managed with 
no history taking by pharmacy before appointment and the 
acceptance by physician. 
Drug related problems Number (%) 
Acceptance by physician (%) 
Accepting Not accepting 
1. Drug choice problem     
1.1 Improper drug 0 0 0 
1.2 Duplicate drug 0 0 0 
1.3 Contraindicated drug 0 0 0 
1.4 Untreated indications 10 (76.9) 5 (50.0) 5 (50.0) 
2. Dosing problem  2 (15.4) 2 (100.0) 0 
3. Drug interaction 0 0 0 
4. Prescribing error 1 (7.7) 1 (100.0) 0 
Total  13 (100.0) 8 (61.5) 5 (38.5) 
 
For 316 patients screened by pharmacists before history 
taking on appointment day, 318 events of drug related 
problems were found (Table 3). The most found drug relation 
problem was blood sugar > 180 mg/dL (199 events or 62.6%).  
On the appointment day, after history taking, of a total of 
302 suspected events ( drug related and non- drug related 
events)  there were no drug related problems in 162 events 
(162 of 302 events or 53.6%), and problems other than drug 
related ones in 11 events of 302 events (3.6%).  
After history taking, of the 302 suspected events (drug 
related and non- drug related events) , 129 drug related 
problems were found (42. 7%) .  The most frequently found 
problems were erroneous drug self-administration (96 events), 
dose self-adjustment (23 events) , and side effects and short 
of supply (5 events each) (Table 3).   
For drug therapy management with no history taking, 
pharmacists recorded the problems and recommendations on 
the information transferal form for the physician. For example, 
for the case of patient in need of given medications or with 
untreated indication as in patients with hyperlipidemia, the 
pharmacist would state on the form the recommendation for 
lipid-lowering agents.  
Physician’ s acceptance for pharmacist’ s drug therapy 
management recommendation is detailed as follows.  It was 
found that before the appointment day, with no history taking, 
of the 13 drug related problems notified to the physician, 8 of 
them were accepted and the regimens were modified 
accordingly ( 61. 5% )  ( Table 2) .  For those management 
recommendations with history taking by pharmacist before 
meeting with the physician, drug related problems were 
recorded on the transferal form along with laboratory findings 
for the physician.  The most frequently found problems were 
self- administration error by the patient.  This problem was 
mainly caused by the unawareness of the modified 
administration, thus the former administration method was 
continued. The pharmacist would inform the physician through 
the information transferal form.  
Of the 129 drug related problems transferred to the 
physician after pharmacist’ s history taking, 82 events were 
accepted and changed according to the pharmacist’ s 
recommendation (63.6%) (Table 4).  
There were 142 events of drug related problems 
transferred to the physician which consisted of 13 events 
without history taking before the appointment day and 129 
events with history taking on the appointment day. There were 
90 drug related problems that the physician provided the 
treatment in accordance with the pharmacist’ s 
recommendation, specifically 8 events without pharmacist’s  
 
 
 Table 3  Number of drug related problems managed with history taking by pharmacy on the appointment day drug related 
problems found on appointment day (N = 316 patients).  
 
Number of drug 
related problems 
BEFORE history 
taking (%) 
Number of events AFTER history taking 
Drug related problems (DRP)  Other problems 
Number of 
patients with 
no DRP 
Side  
effects 
Self-
administration 
error 
Dose  
self-adjusting 
Misunderstandin
g about drug 
Short of  
supply 
Non DRP 
Missed 
appointment 
FBS > 180 mg/dl 199 (62.6) 32 2 55 9 0 4 8 25 
BP > 160/100 mmHg 23 (7.2) 3 0 8 4 0 1 3 5 
Previous dose adjustment 41 (12.9) 7 2 17 5 0 0 0 8 
FBS > 180 mg/dl with previous dose adjustment 47 (14.8) 5 0 14 4 0 0 0 3 
BP > 160/100 mmHg with previous dose adjustment  8 (2.5) 2 1 2 1 0 0 0 2 
Total 318 (100.0) 162 5 96 23 0 5 11 43 
  302*  
   129#   
      
 * suspected events (drug related and non-drug related events) found after history taking, on the appointment day.  
 # drug related problems found after history taking, on the appointment day.  
 Note: DRP = drug related problems.  
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history taking before the appointment day (Table 2)  and 82 
events with history taking by the pharmacist on the 
appointment day (Table 4) .  Therefore 63. 4% ( or 90 of 142 
events) of the transferred events and recommendations were 
accepted by the physician.  Inversely, decisions not in 
agreement with the drug related events and related 
recommendations was found to be 36.6% (or 100 – 63.4%). 
In addition to quantitative outcomes previously mentioned, 
pharmacists also recommended the patient to read labels and 
check for any changes in administration methods. 
Furthermore, for prescriptions with modified administration 
methods, pharmacists were instructed to put signs for direction 
such the up and down arrows for increased and decreased 
doses, respectively, and the underlined text for new or 
modified administration methods.  
 
 Table 4  Number of treatment provided by the physician in 
accordance with drug related problems ( DRPs)  and 
recommendations transferred by the pharmacist after history 
taking.  
DRPs with recommendation 
Number 
of DRP  
Number of treatment by physician (%)  
in accordance with DRP and 
recommendation 
Yes No 
Side effects 5 5 (100.0) 0 (0.0) 
Self-administration error 96 63 (65.6) 33 (34.4) 
Dose self-adjustment 23 9 (39.1) 14 (60.9) 
Misunderstanding about drugs 0 0 0 
Incomplete drug list 5 5 (100.0) 0 (0.0) 
Total 129 82 (63.6) 47 (36.4) 
 
Discussions and Conclusion 
 
Our study developed the drug therapy management 
system with pharmacist participating with the multidisciplinary 
team in the NCD clinic to be suitable for the context of 
Damnoensaduak Hospital, a large- sized community hospital. 
The study was conducted using the participatory action 
research and continuous development of PDCA cycle, and the 
components of the developed system based on the Chronic 
Care Model (CCM) .  It was conducted from November 30, to 
September 15, 2017 with the group of 14 multidisciplinary 
healthcare providers and 1,846 patients.  
The developed system demanded a proactive approach in 
identifying and solving drug related problems before the 
patient could see the physician.  The system also involved 
continuous care on drug use after appointment and the 
participation of the multidisciplinary team.  The process was 
divided into 2 phases, specifically the operation before 
appointment day and the operation on the appointment day. 
Pharmacists involved in 3 steps of execution, namely 
screening for drug related problems, managing drug therapy, 
and transferring information to the physician and patient.  
It was found that before appointment day, 17.8% of drug 
related problems could be screened and identified, and 
additional 42.7%  were identified on the appointment day.  Of 
the cases with drug related problems and recommendations 
transferred to the physician, 63. 4%  were agreed by the 
physician and the drug therapy was modified accordingly.  
Based on the findings from the execution, five issues are 
worthy of discussion, namely, the implementation of CCM 
components, role of pharmacists in the multidisciplinary team, 
screening drug related problems, the outcomes of 
implementing the system in screening drug related problems, 
and participatory action research with the use of PDCA cycle. 
The details are as follows.  
In our study, the implementation of CCM components in 
all steps of development had showed that all components 
were interconnected and unable to be distinguished from each 
other.  Since only five of the six components of CCM, but not 
the community networking component, were used in this 
study, the developed system was only applicable to screening, 
managing and transferring information to the hospital setting. 
As a consequence, drug therapy management and information 
transferal between the hospital and responsible entities in the 
patient community was lacking.  To enhance the efficiency of 
the drug therapy management system, all six components of 
CCM should be incorporated.  
The crucial interconnectivity of all components of CCM has 
been evident in previous studies.  In the study of Siminerio1 1 
where CCM components were applied for diabetes care, the 
components of CCM were inseparable and functioned 
together for a success in diabetes care. In our study, the most 
crucial CCM components were informatics system, self- care 
support system, and decision-making support system.  These 
components were crucial for the success because they 
involved mainly in the ongoing system operation.  Our finding 
was consistent with a systematic review of Davy and 
colleagues1 2  which reported that the most crucial CCM 
components for the success were self- care support system 
and decision-making support system. In addition, they stated 
that components of support among healthcare team members, 
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clear information transferal system, and the support from 
administrators were needed for a sustainable success.12  
In this study, role of pharmacists in the multidisciplinary 
team included screening drug related problems, managing 
drug therapy and transferring the patient information to the 
team members, before the patient could meet the physician. 
This role was critical as also found in the systemic review of 
Beney and colleagues where they concluded that pharmacist 
participating in drug management affected physician 
prescribing pattern in all studies. 1 3  The systematic review of 
Poowaruttanawiwit also stated that one of the crucial roles in 
drug management was preparing the patient’ s information 
before the actual meeting with the physician could help the 
physician and healthcare team to make a sound decision for 
continuous care suitable for individual patients. 1 2  In short, 
pharmacist participating in the multidisciplinary team to screen 
and prepare the patient’ s drug related information before 
meeting with the physician could help improve the treatment. 
However, for patients unable to see the pharmacists before 
physician, the pharmacist consultation could be after the 
physician session with a longer clinic visit required.  
In terms of screening drug related problems screening, we 
used two methods, the information technology assisted and 
the actual pharmacist methods.  Both methods offered a 
relatively comparable efficiency; while no previous studies 
demonstrated such comparisons. A few studies demonstrated 
only the number of drug related problems identified by 
pharmacist participation. 1 4 , 1 5  These two studies used both 
information technology to review laboratory findings and 
history taking by the pharmacist to identify and evaluate drug 
related problems.14,15 In our study, HOSxP database program 
could help screen a large amount of patient data for possible 
drug related problems with a relatively short period of time. 
However, the screening was based on almost solely on data 
of laboratory findings; while more kinds of data, such as 
medication history and laboratory findings from the past 2 – 3 
visits, could be used for manual screening by the pharmacist. 
In conclusion, drug therapy management system with 
pharmacist participating in multidisciplinary team should make 
use of information technology and actual history taking to 
achieve a better outcome.  However, if the workforce of 
pharmacist is limited, information of patients with suspected 
drug related problems from the electronic database should be 
reviewed prior to the actual screening by the pharmacist.  
The fourth issue was the outcomes of implementing the 
drug therapy management system on screening of drug 
related problems.  The system could screen a relative low 
portion of drug related problems, i. e. , 42. 9%.  This rate was 
somewhat lower than other studies where 66.3 – 75.1% of the 
problems were found.14 The most found drug related problem 
in our study was self-administration error (67.1%). This was 
consistent with the work of Lekpet and Pitchayapaibul14 where 
48.2% of drug related problems were non-compliance to drug 
administration.  The agreement of prescribing with the 
recommendations from the pharmacist was 63. 6%  was 
somewhat lower than other studies where the agreement was 
86. 1 –  90. 0% . 1 6 , 1 7  This low agreement rate could be 
attributable to a relatively short period of study time (5 weeks) 
compared to those in other studies of at least of 6 months.  
The use of the participatory action research (PAR) and 
PDCA development cycle could allow the multidisciplinary 
team to share opinions and work together in planning and 
improving the existing system to achieve the drug therapy 
management system suitable for the hospital context.  PAR 
was also used in the study of Khangsri and collagues where 
PAR could help develop working and learning process of 
personnel in alleviating drug dispensing and advice, as well 
as reducing drug related problems among diabetes patients.18 
In our study, PDCA development cycle was incorporated in all 
steps of the development to foster continuous and timely 
improvement. The effectiveness of PDCA was consistent with 
the study of Modthong et al where PDCA in the development 
of OPD service of the medicine department resulted in a more 
effective and safe care for the patient.19 PDCA is suitable for 
continuous development as also found in the study of 
Srisathitnarakun2 0   of which service system was one of the 
systematic problems applicable for cyclical and continuous 
improvement.  Ultimately, to achieve a more effective drug 
therapy management system, multidisciplinary team with 
systematic, continuous planning for improvement should be 
considered the crucial intervention in all settings.  
In conclusion, the improvement of drug therapy 
management system with pharmacist participating in the 
multidisciplinary team using the continuous PDCA cycle and 
CCM components offered a service that could improve 
screening, identifying and solving drug related problems. The 
transferal of the information related to drug related problems 
could be done with less disruption.  This systematic 
improvement has been proven to be useful in the service for 
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NCD patients which comprised the largest portion of OPD 
patients.  It could be useful in improving drug therapy 
management system in other groups of patients where no 
pharmacist participation or their participation is limited to 
achieve a higher level of effectiveness in patient care.  The 
process could also be used to improve the working process 
such as retrieval of patient information from HOSxP for 
transferal system.  More importantly, with a lack or limit of 
workforce and/ or service time, not all patients with diabetes 
and hypertension could be served and not both screening 
system by the pharmacist could be employed simultaneously. 
Thus, one might start with diabetes patients, and the 
screening of drug related problems should be mainly aided 
with the patient informatic system. Future research should be 
extended for at least 6 months to prove a relatively moderate-
term effectiveness and appropriateness of the developed 
system.  Lastly, clinical outcomes evaluation as indicated by 
the concept of the NCD Clinic Plus of the Ministry of public 
Health should be carried out to demonstrate the sustainable, 
real- life clinical outcomes of the developed drug therapy 
management system.  
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